Semaglutide has garnered significant attention in recent years as a groundbreaking treatment for type 2 diabetes and obesity. This medication, a synthetic analogue of glucagon-like peptide-1 (GLP-1), mimics a hormone that plays a crucial role in regulating blood sugar levels and appetite. As the prevalence of obesity and diabetes continues